Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case–Control Study

2019/03/21 by S. Dresden Glockler-Lauf, S. Dresden Glockler‐Lauf, Yaron Finkelstein +3 · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Asthma and respiratory diseases #Phosphodiesterase function and regulation #Medication Adherence and Compliance

paper · doi:10.1016/j.jpeds.2019.02.009

Cited by

• Antibiotic use in children and youths with asthma: a population-based case-control study
• Montelukast use over the past 20 years: monitoring of its effects and safety issues. [europepmc]
• 2020 Brazilian Thoracic Association recommendations for the management of asthma. [europepmc]
• Diagnosis and management of childhood sleep-disordered breathing. Clinical approach. [europepmc]
• Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence. [europepmc]
• Sleep disorders in children with asthma. [europepmc]
• The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children. [europepmc]
• The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study. [europepmc]
• Antibiotic use in children and youths with asthma: a population-based case-control study. [europepmc]
• Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis. [europepmc]
• Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). [europepmc]
• Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review. [europepmc]
• Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19. [europepmc]
• Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series. [europepmc]
• Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. [europepmc]
• Effect of Montelukast sodium combined with Budesonide aerosol on airway function and T lymphocytes in asthmatic children. [europepmc]
• Leukotrienes vs. Montelukast-Activity, Metabolism, and Toxicity Hints for Repurposing. [europepmc]
• Montelukast and Acute Coronary Syndrome: The Endowed Drug. [europepmc]
• Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats. [europepmc]
• Adverse Drug Reactions (ADRs) of Montelukast in Children. [europepmc]
• Evaluation of Neuropsychiatric Effects of Montelukast-Levocetirizine Combination Therapy in Children with Asthma and Allergic Rhinitis. [europepmc]
• Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review. [europepmc]
• Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study. [europepmc]
• Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children. [europepmc]
• Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast Treatment. [europepmc]
• Comparative Risk for Neuropsychiatric Events in Leukotriene Receptor Antagonist vs. Inhaled Corticosteroid in Children With Asthma: A Nationwide Observational Study With a Complementary Analysis Using Natural Language Processing. [europepmc]